The Journal of Immunology, Vol 138, Issue 2 446-451, Copyright © 1987 by American Association of Immunologists

ARTICLES

Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions

JP Portanova, RE Arndt, EM Tan and BL Kotzin

We have identified regions within core histones that are antigenic for autoantibodies in systemic lupus erythematosus (SLE) and drug-induced lupus. An immunoblotting technique was used to determine the reactivity of lupus antibodies for intact histones and for trypsin-resistant histone fragments that lack the amino- and carboxyl-terminal amino acids that are normally exposed in native nucleosomes. In SLE, the predominant anti-histone response was restricted to epitopes in the trypsin-sensitive regions. Of 20 SLE sera that had strong antibody activity for multiple intact histones, 17 showed minimal activity with any of the corresponding trypsin-resistant fragments. A markedly different pattern of reactivity was present in sera of patients with procainamide (Pr)-induced lupus in which antibodies to H2A, H2B, and the H2A-H2B complex had strong fragment activity. Interestingly, recognition of trypsin-resistant fragments was also noted in a small number of SLE sera that contained antibodies to the H2A-H2B complex. In contrast to both SLE and Pr-induced lupus, antibodies induced by hydralazine (Hy) reacted primarily with H3 and H4. Furthermore, these antibodies bound equally well to the corresponding trypsin-resistant regions that are thought to be relatively unexposed in native nucleosomes. Thus, the specificities of anti-histone antibodies in SLE, Pr-induced lupus, and Hy-induced lupus are markedly different, but in each disease reactivity appears to be restricted to a limited number of histone determinants. The data raise the possibility that autoantigen in the form of native nucleosomes may be recognized in SLE and possibly in Pr-induced lupus. In contrast, the propensity of Hy to induce autoantibodies to determinants usually not recognized in SLE or Pr- induced lupus may suggest a different immunogenic stimulus in this disease.

This article has been cited by other articles:

				S Vasoo Drug-induced lupus: an update Lupus, November 1, 2006; 15(11): 757 - 761. [Abstract] [PDF]

				M. Hasegawa, S. Sato, K. Kikuchi, and K. Takehara Antigen specificity of antihistone antibodies in systemic sclerosis Ann Rheum Dis, August 1, 1998; 57(8): 470 - 475. [Abstract] [Full Text]

				S. Sato, M. Fujimoto, H. Ihn, K. Kikuchi, and K. Takehara Antigen Specificity of Antihistone Antibodies in Localized Scleroderma Arch Dermatol, October 1, 1994; 130(10): 1273 - 1277. [Abstract] [PDF]

				L. E. Adams, K. Balakrishnan, S. M. Roberts, R. Belcher, A.-B. Mongey, T.J. Thomas, and E. V. Hess Genetic, Immunologic and Biotransformation Studies of Patients on Procainamide Lupus, April 1, 1993; 2(2): 89 - 98. [Abstract] [PDF]